| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Neuropathies | D003929 | 5 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Dilatation, Pathologic | D004108 | 5 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
| Emphysema | D004646 | 1 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Eye Neoplasms | D005134 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Grauslund J et al. | Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes? | 2010 | Scand. J. Clin. Lab. Invest. | pmid:20205614 |
| Wang L et al. | Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction. | 2010 | Acta Pharmacol. Sin. | pmid:20208552 |
| Zagura M et al. | Association of osteoprotegerin with aortic stiffness in patients with symptomatic peripheral artery disease and in healthy subjects. | 2010 | Am. J. Hypertens. | pmid:20224558 |
| Jurado S et al. | Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. | 2010 | J. Cell. Biochem. | pmid:20225238 |
| Chen CH et al. | Soluble receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation. | 2010 | Clin. Rheumatol. | pmid:20690034 |
| Camozzi V et al. | Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome. | 2010 | Eur. J. Endocrinol. | pmid:19793762 |
| Nezami N et al. | Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. | 2010 | Clin. Biochem. | pmid:20727867 |
| Zhang Y et al. | Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC). | 2010 | Dent Mater | pmid:20728208 |
| Pi M et al. | Impaired osteoblast function in GPRC6A null mice. | 2010 | J. Bone Miner. Res. | pmid:19874200 |
| Secchiero P et al. | Baseline serum concentrations of TRAIL in early rheumatoid arthritis: relationship with response to disease-modifying antirheumatic drugs. | 2010 | J. Rheumatol. | pmid:20472926 |
| Scheres N et al. | Gingival and periodontal ligament fibroblasts differ in their inflammatory response to viable Porphyromonas gingivalis. | 2010 | J. Periodont. Res. | pmid:19778323 |
| Chang IC et al. | Platelet-rich fibrin modulates the expression of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts. | 2010 | J Biomed Mater Res A | pmid:20623670 |
| Aoki S et al. | Function of OPG as a traffic regulator for RANKL is crucial for controlled osteoclastogenesis. | 2010 | J. Bone Miner. Res. | pmid:20560139 |
| Byron CR et al. | In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells. | 2010 | Am. J. Vet. Res. | pmid:20513175 |
| Vik A et al. | Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study. | 2010 | J. Thromb. Haemost. | pmid:20128863 |
| Hughes C et al. | Human single-chain variable fragment that specifically targets arthritic cartilage. | 2010 | Arthritis Rheum. | pmid:20131274 |
| Makihira S et al. | Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. | 2010 | J Mater Sci Mater Med | pmid:19834789 |
| Kadoglou NP et al. | Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. | 2010 | Eur J Vasc Endovasc Surg | pmid:20004120 |
| Tomlins C and Storey A | Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis. | 2010 | Carcinogenesis | pmid:20884685 |
| Rachner TD et al. | Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. | 2010 | Cancer Lett. | pmid:19577359 |
| Bai Y et al. | Formation of bone-like tissue by dental follicle cells co-cultured with dental papilla cells. | 2010 | Cell Tissue Res. | pmid:20886237 |
| Wutzl A et al. | Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. | 2010 | J. Orthop. Res. | pmid:20872578 |
| Wang J and Stern PH | Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA. | 2010 | J. Cell. Biochem. | pmid:20872746 |
| Tan YY et al. | Effects of vascular endothelial growth factor (VEGF) on MC3T3-E1. | 2010 | Orthod Craniofac Res | pmid:21040465 |
| Gallo J et al. | [Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts]. | 2010 | Acta Chir Orthop Traumatol Cech | pmid:21040654 |
| Hesse E et al. | Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. | 2010 | J. Cell Biol. | pmid:21173110 |
| Nabipour I et al. | Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. | 2009 Sep-Oct | Menopause | pmid:19387415 |
| Matsubara K et al. | Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease. | 2009 Nov-Dec | J. Nephrol. | pmid:19967657 |
| Tuchendler D and Bolanowski M | [The role of osteoprotegerin and vitamin D in thyroid pathology]. | 2009 Nov-Dec | Endokrynol Pol | pmid:20041365 |
| GÅ‚uszko P | [Effects of biologic antirheumatic treatments on bone metabolism in rheumatoid arthritis and ankylosing spondylitis]. | 2009 Mar-Apr | Endokrynol Pol | pmid:19396755 |
| Doschak MR et al. | Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. | 2009 Mar-Apr | Mol. Pharm. | pmid:19718808 |
| Corallini F et al. | Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin. | 2009 Jan-Mar | Eur J Histochem | pmid:19351609 |
| Kolar P et al. | Effects of celecoxib on the expression of osteoprotegerin, energy metabolism and cell viability in cultured human osteoblastic cells. | 2009 Jan-Feb | Clin. Exp. Rheumatol. | pmid:19327236 |
| Nihrane A et al. | Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A. | 2009 Jan-Feb | Blood Cells Mol. Dis. | pmid:19014892 |
| Koshikawa M et al. | Elevated osteopontin levels in patients with peripheral arterial disease. | 2009 Feb-Mar | Angiology | pmid:18388057 |
| Le XK et al. | Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. | 2009 Apr-Jun | Indian J Dent Res | pmid:19553712 |
| Shea MK et al. | Vitamin K supplementation and progression of coronary artery calcium in older men and women. | 2009 | Am. J. Clin. Nutr. | pmid:19386744 |
| Xiang GD et al. | Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes. | 2009 | Diabet. Med. | pmid:19388970 |
| Ohishi M et al. | Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. | 2009 | Am. J. Pathol. | pmid:19389927 |
| Guañabens N et al. | High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. | 2009 | J. Bone Miner. Metab. | pmid:19229472 |
| Mogi M and Kondo A | Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19393224 |
| Sun J et al. | Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. | 2009 | Biomed. Pharmacother. | pmid:19231130 |
| Kook SH et al. | Mechanical force inhibits osteoclastogenic potential of human periodontal ligament fibroblasts through OPG production and ERK-mediated signaling. | 2009 | J. Cell. Biochem. | pmid:19206164 |
| Wu XT et al. | Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells. | 2009 | J. Biomed. Mater. Res. Part B Appl. Biomater. | pmid:19165772 |
| Bylski D et al. | Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line. | 2009 | J Biomed Mater Res A | pmid:18449944 |
| Wasilewska A et al. | Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents. | 2009 | J. Pediatr. Endocrinol. Metab. | pmid:20333868 |
| Moran CS et al. | Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. | 2009 | J. Vasc. Res. | pmid:18931513 |
| Flint J et al. | Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children. | 2009 | J. Pediatr. Endocrinol. Metab. | pmid:20333869 |
| Schofer MD et al. | Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers. | 2009 | J Mater Sci Mater Med | pmid:18987945 |
| Xu M et al. | Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. | 2009 | Photomed Laser Surg | pmid:18800943 |
| Nishiura R et al. | Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. | 2009 | Am. J. Nephrol. | pmid:18802328 |
| Kim YD et al. | Expression of receptor activator of nuclear factor -kappaB ligand, receptor activator of nuclear factor -kappaB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats. | 2009 | Lasers Med Sci | pmid:18825474 |
| Whitney MJ et al. | Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. | 2009 | Tissue Eng Part A | pmid:18637760 |
| Chanda D et al. | Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. | 2009 | Clin. Cancer Res. | pmid:19920103 |
| Hozumi A et al. | Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19324007 |
| Kaunitz AM et al. | Postmenopausal osteoporosis: fracture risk and prevention. | 2009 | J Fam Pract | pmid:19891943 |
| Semb AG et al. | Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003. | 2009 | Arterioscler. Thromb. Vasc. Biol. | pmid:19325145 |
| Panizo S et al. | RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. | 2009 | Circ. Res. | pmid:19325147 |
| González-Calvin JL et al. | Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis. | 2009 | J. Clin. Endocrinol. Metab. | pmid:19897681 |
| Tortelli F et al. | Osteoblast and osteoclast differentiation in an in vitro three-dimensional model of bone. | 2009 | Tissue Eng Part A | pmid:19292676 |
| Zhu H et al. | Tumor necrosis factor-alpha alters the modulatory effects of mesenchymal stem cells on osteoclast formation and function. | 2009 | Stem Cells Dev. | pmid:19374589 |
| Zhang N et al. | Relationship between age-related serum concentrations of TGF-beta1 and TGF-beta2 and those of osteoprotegerin and leptin in native Chinese women. | 2009 | Clin. Chim. Acta | pmid:19361465 |
| Kanzaki S et al. | Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. | 2009 | J. Bone Miner. Res. | pmid:18715136 |
| Atkins GJ et al. | Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. | 2009 | Osteoporos Int | pmid:18763010 |
| McCarthy HS et al. | Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. | 2009 | J. Cell. Physiol. | pmid:18814141 |
| Golledge J et al. | A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. | 2009 | Am. J. Hypertens. | pmid:19779468 |
| Stolina M et al. | The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis. | 2009 | J. Clin. Immunol. | pmid:18726678 |
| Schett G et al. | Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. | 2009 | Arthritis Rheum. | pmid:19714640 |
| Kim CH et al. | Effects of high frequency loading on RANKL and OPG mRNA expression in ST-2 murine stromal cells. | 2009 | BMC Musculoskelet Disord | pmid:19728893 |
| Cozzolino M | Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. | 2009 | Blood Purif. | pmid:19729903 |
| Anandarajah AP and Schwarz EM | Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731622 |
| Leibbrandt A and Penninger JM | RANKL/RANK as key factors for osteoclast development and bone loss in arthropathies. | 2009 | Adv. Exp. Med. Biol. | pmid:19731623 |
| Giner M et al. | RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. | 2009 | J. Steroid Biochem. Mol. Biol. | pmid:19073256 |
| Zauli G et al. | Role of full-length osteoprotegerin in tumor cell biology. | 2009 | Cell. Mol. Life Sci. | pmid:19011755 |
| Kostenuik PJ et al. | Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. | 2009 | J. Bone Miner. Res. | pmid:19016581 |
| Van Campenhout A and Golledge J | Osteoprotegerin, vascular calcification and atherosclerosis. | 2009 | Atherosclerosis | pmid:19007931 |
| Yasuhara R et al. | Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. | 2009 | Biochem. J. | pmid:19102726 |
| Ren W et al. | Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. | 2009 | Bone | pmid:19154802 |
| Chiba Y et al. | Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. | 2009 | Gerontology | pmid:19158438 |
| Sims TL et al. | Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. | 2009 | J. Pediatr. Surg. | pmid:19159744 |
| Madarász E et al. | Osteoprotegerin levels in women with prior gestational diabetes mellitus. | 2009 | Diabetes Care | pmid:19114622 |
| Yun HJ et al. | Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha. | 2009 | Rheumatol. Int. | pmid:19116717 |
| Agarwal S et al. | Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. | 2009 | Rheumatol. Int. | pmid:19052752 |
| Terekeci HM et al. | Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. | 2009 | Exp. Clin. Endocrinol. Diabetes | pmid:19053023 |
| Geusens P | Emerging treatments for postmenopausal osteoporosis - focus on denosumab. | 2009 | Clin Interv Aging | pmid:19554095 |
| Sampaio MS et al. | Expression of eight genes of nuclear factor-kappa B pathway in multiple myeloma using bone marrow aspirates obtained at diagnosis. | 2009 | Histol. Histopathol. | pmid:19554506 |
| Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
| Anastasilakis AD et al. | RANKL inhibition for the management of patients with benign metabolic bone disorders. | 2009 | Expert Opin Investig Drugs | pmid:19558335 |
| Yongchaitrakul T et al. | Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. | 2009 | J. Periodont. Res. | pmid:19602124 |
| Reid PE et al. | Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. | 2009 | Mol. Cancer | pmid:19604388 |
| Xu R | Effect of whey protein on the proliferation and differentiation of osteoblasts. | 2009 | J. Dairy Sci. | pmid:19528578 |
| Mesquita M et al. | Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. | 2009 | Clin. Chem. Lab. Med. | pmid:19676147 |
| Kiani AN et al. | Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. | 2009 | J. Rheumatol. | pmid:19648301 |
| Lappin DF et al. | Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. | 2009 | J. Clin. Periodontol. | pmid:19624408 |
| Yokoyama M et al. | Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy. | 2009 | Eur. J. Oral Sci. | pmid:19627347 |
| George A and Evans CA | Detection of root resorption using dentin and bone markers. | 2009 | Orthod Craniofac Res | pmid:19627525 |
| Hartsfield JK | Pathways in external apical root resorption associated with orthodontia. | 2009 | Orthod Craniofac Res | pmid:19627526 |
| Hagedorn C et al. | Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter. | 2009 | Arterioscler. Thromb. Vasc. Biol. | pmid:19661483 |
| Nakamura M et al. | [Osteoclastogenesis and bone resorption]. | 2009 | Nippon Rinsho | pmid:19432105 |
| Masuda H and Tanaka S | [Drugs under development for osteoporosis ]. | 2009 | Nippon Rinsho | pmid:19432120 |